Bruce Buckingham

Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1977)

Fellowship: Children's Hospital Los Angeles (06/1976) CA

Residency: Children's Hospital Los Angeles (06/1974) CA

Board Certification: Pediatric Endocrinology, American Board of Pediatrics (1978)

Medical Education: UCSD School of Medicine (06/1972) CA

Internship: Children's Hospital Los Angeles (06/1973) CA

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., & Wesley, D. M. (2013). Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP). DIABETES TECHNOLOGY & THERAPEUTICS, 15(3), 198-211.

White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study
Aye, T., Barnea-Goraly, N., Ambler, C., Hoang, S., Schleifer, K., & Buckingham, B. A. (2012). White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study. DIABETES CARE, 35(11), 2167-2173.

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., & Ruedy, K. (2012). Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatric diabetes, 13(4), 301-307.

Use of continuous glucose monitoring in children and adolescents
Phillip, M., Danne, T., Shalitin, S., Buckingham, B., Laffel, L., & Battelino, T. (2012). Use of continuous glucose monitoring in children and adolescents. PEDIATRIC DIABETES, 13(3), 215-228.

Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual beta-Cell Function
Sherr, J., Tamborlane, W. V., Xing, D., Tsalikian, E., Mauras, N., & Ruedy, K. (2012). Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual beta-Cell Function. DIABETES CARE, 35(4), 817-820.

Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study
Garg, S., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., & Kaufman, F. R. (2012). Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study. DIABETES TECHNOLOGY & THERAPEUTICS, 14(3), 205-209.

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to < 10 Years
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., & Kollman, C. (2012). A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to < 10 Years. DIABETES CARE, 35(2), 204-210.

The Feasibility of Detecting Neuropsychologic and Neuroanatomic Effects of Type 1 Diabetes in Young Children
Aye, T., Reiss, A. L., Kesler, S., Hoang, S., Drobny, J., & Buckingham, B. A. (2011). The Feasibility of Detecting Neuropsychologic and Neuroanatomic Effects of Type 1 Diabetes in Young Children. DIABETES CARE, 34(7), 1458-1462.

Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes Analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset
Fiallo-Scharer, R., Cheng, J., Beck, R. W., Buckingham, B. A., Chase, H. P., & Xing, D. (2011). Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes Analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. DIABETES CARE, 34(3), 586-590.

A closed-loop artificial pancreas based on risk management.
Cameron, F., Bequette, B. W., Wilson, D. M., Buckingham, B. A., Lee, H., & Niemeyer, G. (2011). A closed-loop artificial pancreas based on risk management. Journal of diabetes science and technology, 5(2), 368-379.

Toward Closing the Loop: An Update on Insulin Pumps and Continuous Glucose Monitoring Systems
Aye, T., Block, J., & Buckingham, B. (2010). Toward Closing the Loop: An Update on Insulin Pumps and Continuous Glucose Monitoring Systems. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 39(3), 609-?.

Insulin Pumps in Young Children
Fuld, K., Conrad, B., Buckingham, B., & Wilson, D. M. (2010). Insulin Pumps in Young Children. DIABETES TECHNOLOGY & THERAPEUTICS, 12, S67-S71.

Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Chase, H. P., Dassau, E., Cobry, E., Clinton, P., & Doyle, F. J. (2010). Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension. DIABETES CARE, 33(5), 1013-1017.

Probabilistic evolving meal detection and estimation of meal total glucose appearance.
Cameron, F., Niemeyer, G., & Buckingham, B. A. (2009). Probabilistic evolving meal detection and estimation of meal total glucose appearance. Journal of diabetes science and technology, 3(5), 1022-1030.

Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Cobry, E., Clinton, P., Gage, V., Caswell, K., & Chase, H. P. (2009). Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension. DIABETES TECHNOLOGY & THERAPEUTICS, 11(2), 93-97.

Duration of Nocturnal Hypoglycemia Before Seizures
Buckingham, B., Wilson, D. M., Lecher, T., Hanas, R., Kaiserman, K., & Cameron, F. (2008). Duration of Nocturnal Hypoglycemia Before Seizures. DIABETES CARE, 31(11), 2110-2112.

Continuous glucose monitoring and intensive treatment of type 1 diabetes
Tamborlane, W. V., Beck, R. W., Bode, B. W., Buckingham, B., Chase, H. P., & Xing, D. (2008). Continuous glucose monitoring and intensive treatment of type 1 diabetes. NEW ENGLAND JOURNAL OF MEDICINE, 359(14), 1464-U65.

Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study
Hirsch, I. B., Abelseth, J., Bode, B. W., Fischer, J. S., Kaufman, F. R., & Buckingham, B. A. (2008). Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study. DIABETES TECHNOLOGY & THERAPEUTICS, 10(5), 377-383.

Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM)
Hirsch, I. B., Armstrong, D., Bergenstal, R. M., Buckingham, B., Childs, B. P., & Wolpert, H. (2008). Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM). DIABETES TECHNOLOGY & THERAPEUTICS, 10(4).

Statistical hypoglycemia prediction.
Cameron, F., Niemeyer, G., Gundy-Burlet, K., & Buckingham, B. (2008). Statistical hypoglycemia prediction. Journal of diabetes science and technology, 2(4), 612-621.

Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator)
Buckingham, B., Xing, D., Weinzimer, S., Fiallo-Scharer, R., Kollman, C., & Beck, R. (2008). Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). PEDIATRIC DIABETES, 9(2), 142-147.

Clinical overview of continuous glucose monitoring.
Buckingham, B. (2008). Clinical overview of continuous glucose monitoring. Journal of diabetes science and technology, 2(2), 300-306.

Detection of a Meal Using Continuous Glucose Monitoring implications for an artificial beta-cell
Dassau, E., Bequette, B. W., Buckingham, B. A., & Doyle, F. J. (2008). Detection of a Meal Using Continuous Glucose Monitoring implications for an artificial beta-cell. DIABETES CARE, 31(2), 295-300.

Continuous glucose monitoring in children with type 1 diabetes
Anonymous. (2007). Continuous glucose monitoring in children with type 1 diabetes. JOURNAL OF PEDIATRICS, 151(4), 388-393.

The medtronic MiniMed gold continuous glucose monitoring system: An effective means to discover hypo- and Hyperglycemia in children under 7 years of age
Gandrud, L. M., Xing, D., Kollman, C., Block, J. M., Kunselman, B., & Buckingham, B. A. (2007). The medtronic MiniMed gold continuous glucose monitoring system: An effective means to discover hypo- and Hyperglycemia in children under 7 years of age. DIABETES TECHNOLOGY & THERAPEUTICS, 9(4), 307-316.

Real-time continuous glucose monitoring.
Buckingham, B., Caswell, K., & Wilson, D. M. (2007). Real-time continuous glucose monitoring. Current opinion in endocrinology, diabetes, and obesity, 14(4), 288-295.

Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm
Wintergerst, K. A., Deiss, D., Buckingham, B., Cantwell, M., Kache, S., & Steil, G. (2007). Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm. DIABETES TECHNOLOGY & THERAPEUTICS, 9(3), 211-222.

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes - The Diabetes Prevention Trial-Type 1
Sosenko, J. M., Palmer, J. P., Greenbaum, C. J., Mahon, J., Cowie, C., & Skyler, J. S. (2007). Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes - The Diabetes Prevention Trial-Type 1. DIABETES CARE, 30(1), 38-42.

Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit
Wintergerst, K. A., Buckingham, B., Gandrud, L., Wong, B. J., Kache, S., & Wilson, D. M. (2006). Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. PEDIATRICS, 118(1), 173-179.

Evaluation of factors affecting CGMS calibration
Buckingham, B. A., Kollman, C., Beck, R. W., Kalajian, A., Fiallo-Scharer, R., & Tamborlane, W. V. (2006). Evaluation of factors affecting CGMS calibration. DIABETES TECHNOLOGY & THERAPEUTICS, 8(3), 318-325.

Extended use of a new continuous glucose monitoring system with wireless data transmission in children with type 1 diabetes mellitus
Wong, L. J., Buckingham, B. A., Kunselman, B., Istoc, E., Leach, J., & Purvis, R. (2006). Extended use of a new continuous glucose monitoring system with wireless data transmission in children with type 1 diabetes mellitus. DIABETES TECHNOLOGY & THERAPEUTICS, 8(2), 139-145.

Vitamin D deficiency in the San Francisco bay area
McAllister, J. C., Lane, A. T., & Buckingham, B. A. (2006). Vitamin D deficiency in the San Francisco bay area. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 19(3), 205-208.

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
Sosenko, J. M., Palmer, J. P., Greenbaum, C. J., Mahon, J., Cowie, C., & Skyler, J. S. (2006). Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. DIABETES CARE, 29(3), 643-649.

The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes
Tansey, M. J. (2006). The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. DIABETES CARE, 29(1), 20-25.

Hypoglycemia detection, and better yet, prevention, in pediatric patients.
Buckingham, B. (2005). Hypoglycemia detection, and better yet, prevention, in pediatric patients. Diabetes technology & therapeutics, 7(5), 792-796.

Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study.
Weinzimer, S. A., Beck, R. W., Chase, H. P., Fox, L. A., Buckingham, B. A., & Ruedy, K. J. (2005). Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes technology & therapeutics, 7(5), 675-680.

Impact of exercise on overnight glycemic control in - Children with type 1 diabetes mellitus
Tsalikian, E., Mauras, N., Beck, R. W., Tamborlane, W. V., Janz, K. F., & White, P. C. (2005). Impact of exercise on overnight glycemic control in - Children with type 1 diabetes mellitus. JOURNAL OF PEDIATRICS, 147(4), 528-534.

Response to nocturnal alarms using a real-time glucose sensor.
Buckingham, B., Block, J., Burdick, J., Kalajian, A., Kollman, C., & Chase, P. (2005). Response to nocturnal alarms using a real-time glucose sensor. Diabetes technology & therapeutics, 7(3), 440-447.

A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.
Chase, H. P., Beck, R., Tamborlane, W., Buckingham, B., Mauras, N., & Xing, D. (2005). A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes care, 28(5), 1101-1106.

The extended Kalman filter for continuous glucose monitoring.
Knobbe, E. J., & Buckingham, B. (2005). The extended Kalman filter for continuous glucose monitoring. Diabetes technology & therapeutics, 7(1), 15-27.

Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.
Tansey, M. J., Beck, R. W., Buckingham, B. A., Mauras, N., Fiallo-Scharer, R., & Ruedy, K. J. (2005). Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes technology & therapeutics, 7(1), 109-114.

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes
Wilson, D. M., Buckingham, B. A., Kunselman, E. L., Sullivan, M. M., Paguntalan, H. U., & Gitelman, S. E. (2005). A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. DIABETES CARE, 28(1), 15-19.

GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.
Tsalikian, E., Kollman, C., Mauras, N., Weinzimer, S., Buckingham, B., & Fiallo-Scharer, R. (2004). GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes technology & therapeutics, 6(5), 559-566.

Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate
Cagle, A. P., Waguespack, S. G., Buckingham, B. A., Shankar, R. R., & DiMeglio, L. A. (2004). Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate. PEDIATRICS, 114(4), 1091-1095.

Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: Results of the Diabetes Research in Children Network (DirecNet) Accuracy study
Mauras, N., Beck, R. W., Ruedy, K. J., KOLLMAN, C., Tamborlane, W. V., & Xing, D. Y. (2004). Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: Results of the Diabetes Research in Children Network (DirecNet) Accuracy study. JOURNAL OF PEDIATRICS, 144(6), 770-775.

Initiation of insulin glargine in children and adolescents with type I diabetes
Tan, C. Y., Wilson, D. M., & Buckingham, B. (2004). Initiation of insulin glargine in children and adolescents with type I diabetes. PEDIATRIC DIABETES, 5(2), 80-86.

Use of the Cygnus GlucoWatch biographer at a diabetes camp
Gandrud, L. M., Paguntalan, H. U., Van Wyhe, M. M., Kunselman, B. L., Leptien, A. D., & Buckingham, B. A. (2004). Use of the Cygnus GlucoWatch biographer at a diabetes camp. PEDIATRICS, 113(1), 108-111.

How should we interpret "real life" conditions.
Eastman, R. C., Chase, H. P., Buckingham, B., Hathout, E., Tamada, J., & Ginsberg, B. (2003). How should we interpret "real life" conditions. Pediatric diabetes, 4(1), 59-?.

Analysis: dawn of real-time continuous glucose sensing.
Buckingham, B. (2003). Analysis: dawn of real-time continuous glucose sensing. Diabetes technology & therapeutics, 5(3), 381-383.

Use of the GlucoWatch biographer in children and adolescents with diabetes.
Eastman, R. C., Chase, H. P., Buckingham, B., Hathout, E. H., Fuller-Byk, L., & Pitzer, K. R. (2002). Use of the GlucoWatch biographer in children and adolescents with diabetes. Pediatric diabetes, 3(3), 127-134.

Cognitive and behavioral characteristics of Turner syndrome: Exploring hormones in female sexual a role for ovarian differentiation
Collaer, M. L., Geffner, M. E., Kaufman, F. R., Buckingham, B., & Hines, M. (2002). Cognitive and behavioral characteristics of Turner syndrome: Exploring hormones in female sexual a role for ovarian differentiation. HORMONES AND BEHAVIOR, 41(2), 139-155.

Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies
Olson, J. A., Olson, D. M., Sandborg, C., Alexander, S., & Buckingham, B. (2002). Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. PEDIATRICS, 109(3).

Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB
Ding, C. L., Buckingham, B., & Levine, M. A. (2001). Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. JOURNAL OF CLINICAL INVESTIGATION, 108(8), 1215-1220.

Intensive diabetes management in pediatric patients.
Buckingham, B., Bluck, B., & Wilson, D. M. (2001). Intensive diabetes management in pediatric patients. Current diabetes reports, 1(1), 11-18.

Prevention of type 1a diabetes mellitus*.
Wilson, D. M., & Buckingham, B. (2001). Prevention of type 1a diabetes mellitus*. Pediatric diabetes, 2(1), 17-24.

A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus
Buckingham, B. A., & Sandborg, C. I. (2000). A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus. CLINICAL IMMUNOLOGY, 96(2), 86-90.

Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus
Berman, M. A., Sandborg, C. I., Wang, Z. S., Imfeld, K. L., Zaldivar, F., & Buckingham, B. A. (1996). Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. JOURNAL OF IMMUNOLOGY, 157(10), 4690-4696.

Self-care behaviors in insulin-dependent diabetes: Evaluative tools and their associations with glycemic control
Hanson, C. L., DEGUIRE, M. J., SCHINKEL, A. M., Kolterman, O. G., Goodman, J. P., & Buckingham, B. A. (1996). Self-care behaviors in insulin-dependent diabetes: Evaluative tools and their associations with glycemic control. JOURNAL OF PEDIATRIC PSYCHOLOGY, 21(4), 467-482.

T-]A TRANSVERSION 11 BP FROM A SPLICE ACCEPTOR SITE IN THE HUMAN GENE FOR STEROIDOGENIC ACUTE REGULATORY PROTEIN CAUSES CONGENITAL LIPOID ADRENAL-HYPERPLASIA
Tee, M. K., LIN, D., Sugawara, T., HOLT, J. A., Guiguen, Y., & Miller, W. L. (1995). T-]A TRANSVERSION 11 BP FROM A SPLICE ACCEPTOR SITE IN THE HUMAN GENE FOR STEROIDOGENIC ACUTE REGULATORY PROTEIN CAUSES CONGENITAL LIPOID ADRENAL-HYPERPLASIA. HUMAN MOLECULAR GENETICS, 4(12), 2299-2305.

IL-4 EXPRESSION IN HUMAN T-CELLS IS SELECTIVELY INHIBITED BY IL-1-ALPHA AND IL-1-BETA
Sandborg, C. I., Imfeld, K. L., Zaldivar, F., Wang, Z. S., Buckingham, B. A., & Berman, M. A. (1995). IL-4 EXPRESSION IN HUMAN T-CELLS IS SELECTIVELY INHIBITED BY IL-1-ALPHA AND IL-1-BETA. JOURNAL OF IMMUNOLOGY, 155(11), 5206-5212.

BIOCHEMICAL-ABNORMALITIES IN VITREOUS OF HUMANS WITH PROLIFERATIVE DIABETIC-RETINOPATHY
SEBAG, J., Buckingham, B., & Charles, M. A. (1992). BIOCHEMICAL-ABNORMALITIES IN VITREOUS OF HUMANS WITH PROLIFERATIVE DIABETIC-RETINOPATHY. ARCHIVES OF OPHTHALMOLOGY, 110(10), 1472-1476.

A NATURALLY-OCCURRING 6-9-KILODALTON INTERLEUKIN-1 (IL-1) INHIBITOR PREVENTS IL-1-MEDIATED ISLET CYTOTOXICITY BUT NOT IL-1-MEDIATED SUPPRESSION OF INSULIN-SECRETION
KAWAHARA, D. J., Everts, M., Buckingham, B., Sandborg, C., & Berman, M. (1991). A NATURALLY-OCCURRING 6-9-KILODALTON INTERLEUKIN-1 (IL-1) INHIBITOR PREVENTS IL-1-MEDIATED ISLET CYTOTOXICITY BUT NOT IL-1-MEDIATED SUPPRESSION OF INSULIN-SECRETION. JOURNAL OF IMMUNOTHERAPY, 10(3), 182-188.

HETEROGENEITY IN THE SPECIFICITY OF THE ISLET CELL CYTOPLASMIC ANTIBODY-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS
KAWAHARA, D. J., Buckingham, B., & Kershnar, A. (1990). HETEROGENEITY IN THE SPECIFICITY OF THE ISLET CELL CYTOPLASMIC ANTIBODY-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS. PANCREAS, 5(6), 647-651.

RELATIONSHIP BETWEEN THE CONTENT OF LYSYL OXIDASE DEPENDENT CROSS-LINKS IN SKIN COLLAGEN, NONENZYMATIC GLYCOSYLATION, AND LONG-TERM COMPLICATIONS IN TYPE-I DIABETES-MELLITUS
Buckingham, B., & Reiser, K. M. (1990). RELATIONSHIP BETWEEN THE CONTENT OF LYSYL OXIDASE DEPENDENT CROSS-LINKS IN SKIN COLLAGEN, NONENZYMATIC GLYCOSYLATION, AND LONG-TERM COMPLICATIONS IN TYPE-I DIABETES-MELLITUS. JOURNAL OF CLINICAL INVESTIGATION, 86(4), 1046-1054.

THE SURGICAL-MANAGEMENT OF HYPERINSULINISM IN INFANCY DUE TO NESIDIOBLASTOSIS
Warden, M. J., GERMAN, J. C., & Buckingham, B. A. (1988). THE SURGICAL-MANAGEMENT OF HYPERINSULINISM IN INFANCY DUE TO NESIDIOBLASTOSIS. JOURNAL OF PEDIATRIC SURGERY, 23(5), 462-465.

INTERFERON RESPONSIVENESS OF NATURAL-KILLER CELLS IN TYPE-I HUMAN DIABETES
Negishi, K., Gupta, S., Chandy, K. G., Waldeck, N., Kershnar, A., & Charles, M. A. (1988). INTERFERON RESPONSIVENESS OF NATURAL-KILLER CELLS IN TYPE-I HUMAN DIABETES. DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 7(1), 49-52.

NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN HUMAN TYPE-1 DIABETES
Negishi, K., Waldeck, N., Chandy, G., Buckingham, B., Kershnar, A., & Charles, A. M. (1987). NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN HUMAN TYPE-1 DIABETES. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 89(3), 345-353.

NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN TYPE-1 (INSULIN-DEPENDENT) DIABETES
Negishi, K., Waldeck, N., Chandy, G., Buckingham, B., Kershnar, A., & Charles, M. A. (1986). NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN TYPE-1 (INSULIN-DEPENDENT) DIABETES. DIABETOLOGIA, 29(6), 352-357.

MULTIPARAMETER IMMUNOLOGICAL STUDIES IN PATIENTS WITH NEWLY DIAGNOSED TYPE-1 INSULIN-DEPENDENT DIABETES-MELLITUS
Gupta, S., Charles, M. A., Waldeck, N., Kershnar, A., & Buckingham, B. (1986). MULTIPARAMETER IMMUNOLOGICAL STUDIES IN PATIENTS WITH NEWLY DIAGNOSED TYPE-1 INSULIN-DEPENDENT DIABETES-MELLITUS. DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 3(5), 225-229.

SKIN, JOINT, AND PULMONARY CHANGES IN TYPE-I DIABETES-MELLITUS
Buckingham, B., PEREJDA, A. J., Sandborg, C., KERSHNAR, A. K., & UITTO, J. (1986). SKIN, JOINT, AND PULMONARY CHANGES IN TYPE-I DIABETES-MELLITUS. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 140(5), 420-423.

COMPLEMENT ACTIVATION IN TYPE-1 HUMAN DIABETES
Sundsmo, J. S., PAPIN, R. A., Wood, L., Hirani, S., Waldeck, N., & Charles, M. A. (1985). COMPLEMENT ACTIVATION IN TYPE-1 HUMAN DIABETES. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 35(2), 211-225.

AUTOLOGOUS MIXED LYMPHOCYTE-REACTION IN MAN .15. CELLULAR AND MOLECULAR-BASIS OF DEFICIENT AUTOLOGOUS MIXED LYMPHOCYTE-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS
Chandy, K. G., Charles, A. M., Kershnar, A., Buckingham, B., Waldeck, N., & Gupta, S. (1984). AUTOLOGOUS MIXED LYMPHOCYTE-REACTION IN MAN .15. CELLULAR AND MOLECULAR-BASIS OF DEFICIENT AUTOLOGOUS MIXED LYMPHOCYTE-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS. JOURNAL OF CLINICAL IMMUNOLOGY, 4(6), 424-428.

SCLERODERMA-LIKE CHANGES IN INSULIN-DEPENDENT DIABETES-MELLITUS - CLINICAL AND BIOCHEMICAL-STUDIES
Buckingham, B. A., UITTO, J., Sandborg, C., Keens, T., Roe, T., & Castellano, A. (1984). SCLERODERMA-LIKE CHANGES IN INSULIN-DEPENDENT DIABETES-MELLITUS - CLINICAL AND BIOCHEMICAL-STUDIES. DIABETES CARE, 7(2), 163-169.

IMMUNOLOGICAL EVENTS IN NEW ONSET DIABETES
CHARLES, M., Suzuki, M., SUNDSMO, J., Waldeck, N., Negishi, K., & Kershnar, A. (1984). IMMUNOLOGICAL EVENTS IN NEW ONSET DIABETES. BIOMEDICA BIOCHIMICA ACTA, 43(5), 615-619.

DEFICIENCY OF MONOCLONAL-ANTIBODY (LEU 7) DEFINED NK-CELLS IN NEWLY DIAGNOSED INSULIN-DEPENDENT DIABETES-MELLITUS
Chandy, K. G., Charles, M. A., Buckingham, B., Waldeck, N., Kershnar, A., & Gupta, S. (1984). DEFICIENCY OF MONOCLONAL-ANTIBODY (LEU 7) DEFINED NK-CELLS IN NEWLY DIAGNOSED INSULIN-DEPENDENT DIABETES-MELLITUS. IMMUNOLOGY LETTERS, 8(2), 89-91.

IMMUNE ISLET KILLING MECHANISMS ASSOCIATED WITH INSULIN-DEPENDENT DIABETES - INVITRO EXPRESSION OF CELLULAR AND ANTIBODY-MEDIATED ISLET CELL CYTO-TOXICITY IN HUMANS
Charles, M. A., Suzuki, M., Waldeck, N., DODSON, L. E., Slater, L., & Golden, M. (1983). IMMUNE ISLET KILLING MECHANISMS ASSOCIATED WITH INSULIN-DEPENDENT DIABETES - INVITRO EXPRESSION OF CELLULAR AND ANTIBODY-MEDIATED ISLET CELL CYTO-TOXICITY IN HUMANS. JOURNAL OF IMMUNOLOGY, 130(3), 1189-1194.

HYPERTHYRODISM IN CHILDREN - A RE-EVALUATION OF TREATMENT
Buckingham, B. A., Costin, G., Roe, T. F., Weitzman, J. J., & KOGUT, M. D. (1981). HYPERTHYRODISM IN CHILDREN - A RE-EVALUATION OF TREATMENT. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 135(2), 112-117.

STUDIES OF IMMUNE-COMPLEX GLOMERULONEPHRITIS MEDIATED BY HUMAN THYROGLOBULIN
Jordan, S. C., Buckingham, B., Sakai, R., & Olson, D. (1981). STUDIES OF IMMUNE-COMPLEX GLOMERULONEPHRITIS MEDIATED BY HUMAN THYROGLOBULIN. NEW ENGLAND JOURNAL OF MEDICINE, 304(20), 1212-1215.

RHABDOMYOLYSIS IN DIABETIC-KETOACIDOSIS
Buckingham, B. A., Roe, T. F., & Yoon, J. W. (1981). RHABDOMYOLYSIS IN DIABETIC-KETOACIDOSIS. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 135(4), 352-354.

THYROIDECTOMY FOR HYPERTHYRODISM IN CHILDREN
Andrassy, R. J., Buckingham, B. A., & Weitzman, J. J. (1980). THYROIDECTOMY FOR HYPERTHYRODISM IN CHILDREN. JOURNAL OF PEDIATRIC SURGERY, 15(4), 501-504.

SURGICAL TREATMENT OF HYPERTHYROIDISM IN CHILDREN
Wesley, J. R., Buckingham, B. A., GAHR, J. A., Isaacs, H., KOGUT, M. D., & Weitzman, J. J. (1977). SURGICAL TREATMENT OF HYPERTHYROIDISM IN CHILDREN. SURGERY GYNECOLOGY & OBSTETRICS, 145(3), 343-346.

PATHOLOGIC AND IMMUNE FACTORS IN THYROID DISEASE
Buckingham, B. A., Costin, G., KOGUT, M. D., Isaacs, H., & Landing, B. H. (1977). PATHOLOGIC AND IMMUNE FACTORS IN THYROID DISEASE. JOURNAL OF PEDIATRICS, 91(5), 728-733.

THYROID-FUNCTION IN CHILDREN WITH CHRONIC RENAL-FAILURE
Wassner, S. J., Buckingham, B. A., KERSHNAR, A. J., MALEKZADEH, M. H., Pennisi, A. J., & Fine, R. N. (1977). THYROID-FUNCTION IN CHILDREN WITH CHRONIC RENAL-FAILURE. NEPHRON, 19(4), 236-241.